A Massachusetts-based pharmaceutical company announced it signed an agreement to acquire Rockville biotechnology firm Vigene Biosciences, Inc. on Research Court. Charles River Laboratories International, Inc. said it expects to purchase Vigene Biosciences for $292.5 million, subject to some adjustments. The purchase includes contingent future payments of up to $57.5 million based on performance, according to […]
Vigene Biosciences
May 20, 2021 |
July 23, 2020 |
Two Maryland Companies Join Forces to Manufacture Potential COVID-19 Vaccine
Two Maryland companies are partnering to manufacture a potential vaccine candidate for COVID-19. Gaithersburg-based Altimmune, a clinical stage biopharmaceutical company and Vigene Biosciences, a Rockville-based biotechnology company, announced the partnership in a press release July 22. The vaccine, known as AdCOVID (TM), works to block infection by stimulating antibodies in the nasal cavity and can […]
January 30, 2020 |
Biosciences Facility in Rockville Striving to Help Cure Serious Diseases
Maryland’s booming biotech field just added a major new facility. Vigene Biosciences opened its new headquarters in Rockville on Wednesday and officials say it’s a pioneer in gene therapy. The $20 million, state-of-the-art facility will be a place where scientists can work towards curing serious and rare diseases. Vigene Biosciences COO, Dr. Jeffrey Hung says […]
Engage us on Facebook
Follow us on Twitter
Tweets by @mymcmedia